<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00733343</url>
  </required_header>
  <id_info>
    <org_study_id>01</org_study_id>
    <secondary_id>ISRCTN19572887</secondary_id>
    <nct_id>NCT00733343</nct_id>
  </id_info>
  <brief_title>Treatment of Predominant Central Sleep Apnoea by Adaptive Servo Ventilation in Patients With Heart Failure</brief_title>
  <acronym>Serve-HF</acronym>
  <official_title>Treatment of Sleep-Disordered Breathing With Predominant Central Sleep Apnea by Adaptive Servo Ventilation in Patients With Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ResMed</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CRI-The Clinical Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>ResMed</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to evaluate the long-term effects and cost-effectiveness of
      adaptive servo-ventilation (ASV) on the mortality and morbidity of patients with stable heart
      failure due to left ventricular systolic dysfunction, already receiving optimal medical
      therapy, who have sleep disordered breathing (SDB) that is predominantly central sleep apnea.
      Assumptions: the intervention reduces the hazard rate by 20%. The event rate in the control
      group is 35% in the first year. It is assumed that the hazard rate is constant over time.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: The purpose of this trial is to evaluate the long-term effects and
      cost-effectiveness of adaptive servo-ventilation (ASV) on the mortality and morbidity of
      patients with stable heart failure due to left ventricular systolic dysfunction, already
      receiving optimal medical therapy, who have sleep disordered breathing (SDB) that is
      predominantly central sleep apnea.

      Study Design: Randomized, multicentre, international trial with parallel group design, with
      patients randomized to either control (optimal medical management) or active treatment
      (optimal medical treatment plus use of adaptive servoventilation) in a 1:1 ratio. There will
      be no sham-positive airway pressure treatment in the control arm. Assumptions: the
      intervention reduces the hazard rate by 20%. The event rate in the control group is 35% in
      the first year. It is assumed that the hazard rate is constant over time. The trial is an
      event driven design: the final analysis is to be performed latest when 651 events have been
      observed. The primary analysis is in the intention-to-treat population that consists of all
      patients randomized.

      Number of Patients: 1116 patients will be randomly assigned to one of the two treatment
      groups. A 20% drop out rate is estimated.

      Selection criteria: Patients at the age of or over 22 years with severe chronic heart failure
      (chronic HF), New York Heart Association (NYHA) class III-IV or NYHA class II with at least
      one hospitalization for HF within the last 24 months, with Left Ventricular Ejection Fraction
      (LVEF) less or equal 45% by means of echocardiography, radionuclide ventriculography or
      cardiac MRI and Sleep Disordered Breathing (SDB) (apnoea-hypopnoea-index (AHI &gt; 15/h) with
      50% central events and a central AHI â‰¥ 10/h, no change of medication and no hospitalization
      for more than 1 month before randomization and medical therapy according to the applicable
      guidelines (European Society of Cardiology (ESC) and American College of Cardiology/American
      Heart Association (ACC/AHA) respectively).

      Primary Endpoints: Time to first event of:

        1. all cause mortality or unplanned hospitalisation/prolongation of hospitalisation for
           worsening heart failure

        2. cardiovascular mortality or unplanned hospitalisation/prolongation of hospitalisation
           for worsening heart failure.

        3. all cause mortality or all cause unplanned hospitalisation/prolongation of
           hospitalisation Heart transplantation, appropriate shock from implantable
           cardioverter-defibrillator (ICD), long term assist device (LTAD) insertion and survived
           resuscitation of sudden cardiac arrest are counted as cardiovascular death, survived
           resuscitation for other reasons is counted as all cause death.

      The three combinations are not tested in parallel but in this hierarchical order.

      Secondary Endpoints : Time until death, non cardiovascular death, cardiovascular death,
      hospitalization due to deterioration of heart failure or cardiovascular death,
      hospitalization for other reasons or death, hospitalization for cardiovascular cause or
      cardiovascular death, percent of follow-up (FU) days which patient survives and is not
      hospitalized for cardiovascular cause, percent of follow up days which patient survives and
      is not hospitalized for other reason, time to first adequate shock (in patients with ICD,
      evaluation of appropriateness will also be made by the ERC) or cardiovascular death, changes
      in NYHA class as compared to baseline, changes in difference in health costs between the two
      treatment groups, changes in QoL (Minnesota, Euroqol 5D (EQ5D)) as compared to baseline,
      changes in renal function (based on serum creatinine) as compared to baseline, changes in
      result of Six Minute Walking Test (6MWT) (50) as compared to baseline,changes of AHI and
      oxygen desaturation index compared to baseline, AHI below 10 per hour at twelve months and
      Oxygen desaturation index (ODI) below 5 per hour at twelve months, atrial fibrillation at
      follow-up visits.

      Number and cost of hospitalizations (with tariff/diagnostic-related Group (DRG), diagnoses
      and procedures for calculating DRG or length of stay and level of care provided), cost of
      care (technology and service, nursing, physicians visit) related to ventilation, difference
      in utilities / QoL (Minnesota and EQ5D) compared to control arm, difference in cost of
      resources consumed, cost-efficacy, cost-utility. Secondary target parameters will be measured
      at the last follow up or at the last available observation within FU.

      Scheduled follow up : Minimum follow up time will be 24 months, maximum about 70 months.
      There will be a final assessment for each patient at the end of the study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All Cause Mortality or Unplanned Hospitalisation/Prolongation of Hospitalisation for Worsening Heart Failure</measure>
    <time_frame>time to first event, assessed for up to 70 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiovascular Mortality or Unplanned Hospitalisation/Prolongation of Hospitalisation for Worsening Heart Failure</measure>
    <time_frame>time to first event, assessed for up to 70 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>All Cause Mortality or All Cause Unplanned Hospitalisation/Prolongation of Hospitalisation</measure>
    <time_frame>time to first event, assessed for up to 70 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Death From Any Cause</measure>
    <time_frame>the last follow up or at the last available observation within Follow Up (FU), assessed for up to 70 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-cardiovascular Death</measure>
    <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular Death</measure>
    <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unplanned Hospitalisation/Prolongation of Hospitalisation Due to Worsening of Heart Failure</measure>
    <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unplanned Hospitalisation/Prolongation of Hospitalisation for Other Reasons or Death</measure>
    <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adequate Shock in Patients With ICD (Evaluation of Appropriateness Will Also be Made by the Endpoint Review Committee, ERC), Long-Term Atrial Defibrillator Insertion or Cardiovascular Death</measure>
    <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First Survived Resuscitation for Any Reason (Evaluation Will Also be Made by the ERC)</measure>
    <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First Survived Resuscitation of Sudden Cardiac Arrest (Evaluation Will Also be Made by the ERC)</measure>
    <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Age Baseline</measure>
    <time_frame>1 x at Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Weight Baseline</measure>
    <time_frame>1 x at baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index (BMI) Baseline</measure>
    <time_frame>1 x baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left Ventricular Ejection Fraction at Baseline</measure>
    <time_frame>1x at baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure Systolic Baseline</measure>
    <time_frame>1 x at baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure Diastolic Baseline</measure>
    <time_frame>1 x at baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemoglobine Baseline</measure>
    <time_frame>1 x at baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Creatinine Baseline</measure>
    <time_frame>1 x at baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glomerular Filtration Rate Baseline</measure>
    <time_frame>1 x at baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6-Min Walk Distance</measure>
    <time_frame>1 x at baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Epworth Sleepiness Scale (ESS)</measure>
    <time_frame>1 x at baseline</time_frame>
    <description>Measure Description: ESS is a self-administered questionnaire. It contains 8 questions. Questions are rated on a 4-point Likert scale (0-3); 0= would never doze, 3=high Chance of dozing. Range of scores 0-24. Global score= sum of all item scores. Copyright (c)MW Johns</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apnoea-Hypopnea-Index (AHI) at Baseline</measure>
    <time_frame>1 x at baseline</time_frame>
    <description>Measure Description: The AHI is an index to describe the severity of Sleep Apnea. Apnea is cessation of breathing during sleep. Hypopnea is diminished breathing during sleep. The number of Apneas and Hypopneas are added up and divided by hours of sleep (Apneas + Hypopneas per hour). An AHI ranging from 5-15 describes mild Sleep Apnea. AHI 15-30 describes moderate Sleep Apnea. AHI &gt;30 describes severe Sleep Apnea.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central Apnoea Index/Total AHI</measure>
    <time_frame>1 x at baseline</time_frame>
    <description>Measure Description: Central apneas are partial or complete cessations of airflow caused by reduced or stopped neural Stimulation of the breathing muscles. For comparison: In obstructive apneas are caused by blocked airways that shut off the air although the breathing Stimulus is working.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central AHI/Total AHI at Baseline</measure>
    <time_frame>1 x at baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen Desaturation Index (ODI) at Baseline</measure>
    <time_frame>1 x at baseline</time_frame>
    <description>Number of oxygen desaturations per hour at baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen Saturation Baseline</measure>
    <time_frame>1 x at baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time With Oxygen Saturation Below 90%</measure>
    <time_frame>1 x at baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time Until Unplanned Hospitalisation/Prolongation of Hospitalisation for Cardiovascular Cause or Cardiovascular Death/ Time Frame</measure>
    <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent of Follow up Days Which Patient Survives and is Not Hospitalized/Hospital Stay is Not Prolonged for Cardiovascular Cause</measure>
    <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in NYHA Classification as Compared to Baseline</measure>
    <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in QoL (Minnesota) as Compared to Baseline</measure>
    <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Renal Function (Based on Serum Creatinine) as Compared to Baseline</measure>
    <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Six Minute Walking Distance (6MWD) as Compared to Baseline</measure>
    <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of AHI and Oxygen Desaturation Index Compared to Baseline</measure>
    <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AHI Below 10 Per Hour at Twelve Months and ODI Below 5 Per Hour at Twelve Months</measure>
    <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Atrial Fibrillation at Follow-up Visits</measure>
    <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and Cost of Hospitalisations (With Tariff/DRG, Diagnoses and Procedures for Calculating DRG or Length of Stay and Level of Care Provided)</measure>
    <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in Utilities / QoL (Minnesota and EQ5D) Compared to Control Arm</measure>
    <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in Cost of Resources Consumed</measure>
    <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental Cost-efficacy Ratio</measure>
    <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental Cost-utility Ratio</measure>
    <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1325</enrollment>
  <condition>Heart Failure</condition>
  <condition>Sleep Disordered Breathing</condition>
  <arm_group>
    <arm_group_label>Treatment Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP (Variable Positive Airway Pressure) Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Europe: AutoSet CS (USA: VPAP Adapt SV)</intervention_name>
    <description>At least 3 hours average daily usage time</description>
    <arm_group_label>Treatment Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients must be at least 22 years old

          -  Chronic heart failure (at least 12 weeks since diagnosis) according to the current
             applicable guidelines (ESC, ACC/AHA)

          -  Left ventricular systolic dysfunction (LVEF â‰¤45% by imaging method such as
             echocardiography, radionuclide angiography, left ventriculography, or cardiac magnetic
             resonance imaging) documented less than 12 weeks before randomisation

          -  NYHA class III or IV at the time of inclusion or NYHA class II with at least one
             hospitalisation for HF in the last 24 months

          -  No hospitalisation for heart failure for at least 4 weeks prior to inclusion

          -  Optimised medical treatment according to applicable guidelines with no new class of
             disease modifying drug for more than 4 weeks prior to randomisation. In case of no
             beta blockers or ACE (angiotensin converting Enzyme) inhibitors/ ARB (angiotensin
             receptor blocker) antagonists the reasons must be documented

          -  SDB (AHI &gt; 15/h with â‰¥ 50% central events and a central AHI â‰¥ 10/h, derived from
             polygraphy or polysomnography (based on total recording time (TRT)), documented less
             than 4 weeks before randomisation. Flow measurement has to be performed with nasal
             cannula

          -  Patients for whom the use of AutoSet CS2 (TM)/VPAP Adapt may be contra-indicated
             because of symptomatic hypotension or significant intravascular volume depletion or
             pneumothorax or pneumomediastinum

          -  Patient is able to fully understand study information and signed informed consent

        Exclusion Criteria:

          -  Significant COPD (chronic obstructive pulmonary disease) with Forced Expiratory Volume
             within one second (FEV1) &lt;50% (European Respiratory Society criteria) in the last four
             weeks before randomisation

          -  Oxygen saturation at rest during the day â‰¤ 90% at inclusion

          -  Current use of Positive Airway Pressure (PAP) - therapy

          -  Life expectancy &lt; 1 year for diseases unrelated to chronic HF

          -  Cardiac surgery, Percutaneous coronary intervention (PCI), Myocardial Infarction (MI)
             or unstable angina within 6 months prior to randomisation

          -  CRT (cardiac resynchronisation therapy)-implantation or ICD-implantation scheduled or
             within 6 months prior to randomisation

          -  Transient ischemic attack (TIA) or Stroke within 3 months prior to randomisation

          -  Primary hemodynamically significant uncorrected valvular heart disease, obstructive or
             regurgitant, or any valvular disease expected to lead to surgery during the trial

          -  Acute myocarditis/pericarditis within 6 months prior to randomisation

          -  Untreated or therapy refractory Restless legs-Syndrome (RLS) according to criteria
             listed in Appendix IX at the time of study entry

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helmut Teschler, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>UniversitÃ¤tsklinikum Essen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martin Cowie, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Heart and Lung Institute (NHLI) Brompton Hospital, London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Westmead Hospital</name>
      <address>
        <city>Westmead</city>
        <state>New South Wales</state>
        <zip>2145</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rivercity Private Hospital</name>
      <address>
        <city>Auchenflower</city>
        <state>Queensland</state>
        <zip>4066</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Adelaide Hospital</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <zip>5000</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Melbourne Sleep Disorders Centre</name>
      <address>
        <city>East Melbourne</city>
        <state>Victoria</state>
        <zip>3002</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Vincents and Mercy Private Hospital</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3065</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hollywood Private Hospital (CVS)</name>
      <address>
        <city>Nedlands</city>
        <state>Western Australia</state>
        <zip>6009</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Anne's University Hospital BRNO</name>
      <address>
        <city>Brno</city>
        <zip>65691</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bispebjerg Hospital</name>
      <address>
        <city>Copenhagen</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dansk Center For SÃ¸vnmedicin</name>
      <address>
        <city>Glostrup</city>
        <zip>2600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Glostrup Hospital</name>
      <address>
        <city>Glostrup</city>
        <zip>2600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ã…rhus Universitets Hospital</name>
      <address>
        <city>Ã…rhus C</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ã…rhus Universitets Hospital Skejby</name>
      <address>
        <city>Ã…rhus N</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00290</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unesta Research Centre</name>
      <address>
        <city>Tampere</city>
        <zip>33520</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital, Pirkanmaa sairaanhoitopiiri</name>
      <address>
        <city>Tampere</city>
        <zip>33521</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiologist Dr. Papola</name>
      <address>
        <city>Amneville</city>
        <zip>57360</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Angers</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier d'Antibes Juan-les-Pins</name>
      <address>
        <city>Antibes</city>
        <zip>06606</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Prive d'Antony</name>
      <address>
        <city>Antony</city>
        <zip>92166</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Belfort</name>
      <address>
        <city>Belfort</city>
        <zip>90000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Besancon</name>
      <address>
        <city>Besancon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de BÃ©ziers</name>
      <address>
        <city>Beziers</city>
        <zip>34525</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique du Tondu</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HÃ´pital St. AndrÃ©</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Cardiologique Dr. Puel</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Cardiologique Dr. Wickers</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Bordeaux, Hopital Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Caen</name>
      <address>
        <city>Caen Cedex</city>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Cannes</name>
      <address>
        <city>Cannes</city>
        <zip>06401</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Henri Mondor</name>
      <address>
        <city>Creteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HÃ´pital Sud</name>
      <address>
        <city>Echirolles</city>
        <zip>38434</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Forbach, Hospitalor, Hopital Marie Madeleine-Pneumology</name>
      <address>
        <city>Forbach</city>
        <zip>57604</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Forbach-Cardiology</name>
      <address>
        <city>Forbach</city>
        <zip>57604</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Mutualiste des Eaux Claires</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Grenoble, Hopital Michallon</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Haguenau</name>
      <address>
        <city>Haguenau</city>
        <zip>67504</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique de L'Union</name>
      <address>
        <city>L'Union</city>
        <zip>31240</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Lille- Hopital Cardiologique</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Lille-Sleep medicine</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polyclinique La Louviere</name>
      <address>
        <city>Lille</city>
        <zip>59042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospices Civils de Lyon, Hopital de la Croix-Rousse</name>
      <address>
        <city>Lyon</city>
        <zip>69317</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHR Metz, HÃ´pital de Bon-Secours</name>
      <address>
        <city>Metz</city>
        <zip>57000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Montbeliard</name>
      <address>
        <city>Montbeliard</city>
        <zip>25209</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Intercommunal AndrÃ© GrÃ©goire</name>
      <address>
        <city>Montreuil</city>
        <zip>93105</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Mulhouse, Hopital Emile Muller</name>
      <address>
        <city>Mulhouse</city>
        <zip>68070</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique les Fleurs</name>
      <address>
        <city>Ollioules</city>
        <zip>83190</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HÃ´pital Bichat</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Tenon</name>
      <address>
        <city>Paris</city>
        <zip>75790</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Bordeaux, Hopital Haut Leveque</name>
      <address>
        <city>Pessac</city>
        <zip>33600</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet de cardiologie</name>
      <address>
        <city>Pont-Ã -mousson</city>
        <zip>54700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Rene Dubos</name>
      <address>
        <city>Pontoise</city>
        <zip>95303</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polyclinique Saint-Laurent</name>
      <address>
        <city>Rennes</city>
        <zip>35706</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Rouen, Hopital de Bois Guillaume</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Lemire - St Avold</name>
      <address>
        <city>Saint Avold</city>
        <zip>BP 30011</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique des Trois FrontiÃ¨res</name>
      <address>
        <city>Saint Louis</city>
        <zip>68300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Saint-Etienne, Hopital Nord</name>
      <address>
        <city>Saint- Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de St DiÃ© des Vosges</name>
      <address>
        <city>St DiÃ© des Vosges</city>
        <zip>88187</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Toulouse, Hopital de Rangueil</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Toulouse, Hopital Larrey</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Trouville</name>
      <address>
        <city>Trouville</city>
        <zip>14360</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Nancy, Hopital Brabois</name>
      <address>
        <city>Vandoeuvre les Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ch St. Nicolas</name>
      <address>
        <city>Verdun</city>
        <zip>55100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiopraxis Ingelheim</name>
      <address>
        <city>Ingelheim Am Rhein</city>
        <state>Rheinland-Pfalz</state>
        <zip>55218</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Frieske</name>
      <address>
        <city>Aachen</city>
        <zip>52062</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinikum Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DRK Krankenhaus</name>
      <address>
        <city>Alzey</city>
        <zip>55232</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis WeiÃŸ / Dr. Heesing</name>
      <address>
        <city>Arnsberg</city>
        <zip>59821</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zentralklinikum Bad Berka</name>
      <address>
        <city>Bad Berka</city>
        <zip>99437</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Bad Krozingen</name>
      <address>
        <city>Bad Krozingen</city>
        <zip>79189</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik Lazariterhof</name>
      <address>
        <city>Bad Krozingen</city>
        <zip>79189</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Schlaflabor Breisgau</name>
      <address>
        <city>Bad Krozingen</city>
        <zip>79189</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Bauer</name>
      <address>
        <city>Bad Mergentheim</city>
        <zip>97980</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herz- und Diabeteszentrum NRW</name>
      <address>
        <city>Bad Oeynhausen</city>
        <zip>32545</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oberlausitz-Kliniken gGmbH</name>
      <address>
        <city>Bautzen</city>
        <zip>02625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologie BrÃ¼hl</name>
      <address>
        <city>Bergheim</city>
        <zip>50126</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiopraxis Rheinberg</name>
      <address>
        <city>Bergisch Gladbach</city>
        <zip>51465</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CharitÃ© Campus Mitte - Kardiologie</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CharitÃ© Campus Mitte CCM- Schlafmedizinisches Zentrum</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>POLIKUM Friedenau</name>
      <address>
        <city>Berlin</city>
        <zip>12157</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis GroÃŸ-Ziethener Chaussee</name>
      <address>
        <city>Berlin</city>
        <zip>12355</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unfallkrankenhaus Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>12683</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Evangelische Lungenfachklinik Buch</name>
      <address>
        <city>Berlin</city>
        <zip>13125</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>JÃ¼disches Krankenhaus Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13347</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CharitÃ© Campus Virchow Klinikum</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Westend</name>
      <address>
        <city>Berlin</city>
        <zip>14050</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Brandenburg</name>
      <address>
        <city>Bernau</city>
        <zip>16321</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis fÃ¼r Lunge, Herz und Schlaf</name>
      <address>
        <city>Bielefeld</city>
        <zip>33617</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologie Gemeinschaftspraxis Dres Tenholt&amp;Metzger&amp;Dexling</name>
      <address>
        <city>Bochum</city>
        <zip>44787</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinikum Bergmannsheil</name>
      <address>
        <city>Bochum</city>
        <zip>44789</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Augusta Krankenanstalten Bochum</name>
      <address>
        <city>Bochum</city>
        <zip>44791</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St.-Josephs-Hospital</name>
      <address>
        <city>Bochum</city>
        <zip>44791</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologie Kemnade</name>
      <address>
        <city>Bochum</city>
        <zip>44797</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Staubach</name>
      <address>
        <city>Bochum</city>
        <zip>44866</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinikum Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>53127</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Marschner</name>
      <address>
        <city>Bonn</city>
        <zip>53225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helios Klinikum Borna</name>
      <address>
        <city>Borna</city>
        <zip>04552</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Kardiologie</name>
      <address>
        <city>Bottrop</city>
        <zip>46236</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Bremen Ost</name>
      <address>
        <city>Bremen</city>
        <zip>28325</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologie BrÃ¼hl</name>
      <address>
        <city>BrÃ¼hl</city>
        <zip>50321</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mediclin Rehazentrum Spreewald</name>
      <address>
        <city>Burg</city>
        <zip>03096</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Kardiologie Dr. Becker</name>
      <address>
        <city>Castrop-Rauxel</city>
        <zip>44575</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Isbruch</name>
      <address>
        <city>Castrop-Rauxel</city>
        <zip>44577</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MVZ am KÃ¼chwald</name>
      <address>
        <city>Chemnitz</city>
        <zip>09113</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Coburg GmbH</name>
      <address>
        <city>Coburg</city>
        <zip>96450</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fachkrankenhaus Coswig</name>
      <address>
        <city>Coswig</city>
        <zip>01640</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carl-Thiem-Klinikum gGmbH</name>
      <address>
        <city>Cottbus</city>
        <zip>03042</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ambulantes Zentrum fÃ¼r Lungenkrankheiten&amp;Schlafmedizin</name>
      <address>
        <city>Cottbus</city>
        <zip>03050</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MECS Cottbus GmbH</name>
      <address>
        <city>Cottbus</city>
        <zip>03050</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Hecker</name>
      <address>
        <city>Dortmund</city>
        <zip>44135</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Golling</name>
      <address>
        <city>Dortmund</city>
        <zip>44137</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Trial Site Services</name>
      <address>
        <city>Dortmund</city>
        <zip>44141</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Wetzel</name>
      <address>
        <city>Dortmund</city>
        <zip>44141</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Lodde</name>
      <address>
        <city>Dortmund</city>
        <zip>44147</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. DrÃ¶se</name>
      <address>
        <city>Dortmund</city>
        <zip>44263</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Facharztzentrum Dresden-Neustadt GbR</name>
      <address>
        <city>Dresden</city>
        <zip>01099</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Dres. Schmidt/Gronke</name>
      <address>
        <city>Dresden</city>
        <zip>01219</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Hohensee</name>
      <address>
        <city>Dresden</city>
        <zip>01277</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herzzentrum UniversitÃ¤t Dresden</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>goMedus Gesundheitszentrum</name>
      <address>
        <city>DÃ¼sseldorf</city>
        <zip>40212</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Horowitz</name>
      <address>
        <city>DÃ¼sseldorf</city>
        <zip>40215</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus</name>
      <address>
        <city>DÃ¼sseldorf</city>
        <zip>40217</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Raff</name>
      <address>
        <city>DÃ¼sseldorf</city>
        <zip>40237</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Florence-Nightingale Krankenhaus</name>
      <address>
        <city>DÃ¼sseldorf</city>
        <zip>40489</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologie Oberkassel</name>
      <address>
        <city>DÃ¼sseldorf</city>
        <zip>40545</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis PD. Dr. Lankisch</name>
      <address>
        <city>DÃ¼sseldorf</city>
        <zip>40597</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>FachÃ¤rzte fÃ¼r Innere Medizin Dres Ritter, Richter, Mehrer, Kahl</name>
      <address>
        <city>Emmendingen</city>
        <zip>79312</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helios Klinikum Erfurt-Kardiologie</name>
      <address>
        <city>Erfurt</city>
        <zip>99089</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helios Klinikum Erfurt-Schlafmedizin</name>
      <address>
        <city>Erfurt</city>
        <zip>99089</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinikum Erlangen</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westdeutsches Herzzentrum, UniversitÃ¤tsklinikum Essen</name>
      <address>
        <city>Essen</city>
        <zip>45122</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Cord MÃ¼ller</name>
      <address>
        <city>Essen</city>
        <zip>45131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Schwerpunktpraxis Kardiologie Drs. Ophoff/Fritzsch</name>
      <address>
        <city>Essen</city>
        <zip>45131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Prof. Winter</name>
      <address>
        <city>Essen</city>
        <zip>45134</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologie Praxis Dr. Bonnekamp</name>
      <address>
        <city>Essen</city>
        <zip>45136</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Tekiyeh</name>
      <address>
        <city>Essen</city>
        <zip>45136</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Elisabeth-Krankenhaus Essen</name>
      <address>
        <city>Essen</city>
        <zip>45138</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ruhrlandklinik Essen</name>
      <address>
        <city>Essen</city>
        <zip>45239</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Rau</name>
      <address>
        <city>Essen</city>
        <zip>45276</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kath. Kliniken Essen / Philippusstift</name>
      <address>
        <city>Essen</city>
        <zip>45359</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Dres. Guckenbiehl</name>
      <address>
        <city>Flonheim</city>
        <zip>55237</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Kruse</name>
      <address>
        <city>Forst</city>
        <zip>03149</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CardioVasculÃ¤res Centrum Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <zip>60389</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Diedrichs</name>
      <address>
        <city>Frechen</city>
        <zip>50226</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Freiburg</name>
      <address>
        <city>Freiburg im Breisgau</city>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Dres. BÃ¶hmeke/Schmidt</name>
      <address>
        <city>Gladbeck</city>
        <zip>45964</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Hug</name>
      <address>
        <city>GÃ¼nzburg</city>
        <zip>89312</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis GÃ¼tersloh</name>
      <address>
        <city>GÃ¼tersloh</city>
        <zip>33334</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Dres Leischik/Littwitz</name>
      <address>
        <city>Hagen</city>
        <zip>58095</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Arens</name>
      <address>
        <city>Hagen</city>
        <zip>58095</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Dres. Subin/Lutter</name>
      <address>
        <city>Hamburg</city>
        <zip>20095</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios Klinik Barmbek</name>
      <address>
        <city>Hamburg</city>
        <zip>22291</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Internistenpraxis Alstertal Hamburg</name>
      <address>
        <city>Hamburg</city>
        <zip>22399</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Cierpka</name>
      <address>
        <city>Hannover</city>
        <zip>30159</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. HÃ¶tte</name>
      <address>
        <city>Hannover</city>
        <zip>30449</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Siloah Krankenhaus</name>
      <address>
        <city>Hannover</city>
        <zip>30449</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Hartung</name>
      <address>
        <city>Hannover</city>
        <zip>30559</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MH Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Hannover Oststadt-Heidehaus</name>
      <address>
        <city>Hannover</city>
        <zip>30659</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Durak</name>
      <address>
        <city>Heidelberg</city>
        <zip>69115</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thoraxklinik Heidelberg gGmbH</name>
      <address>
        <city>Heidelberg</city>
        <zip>69126</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lungenklinik Hemer</name>
      <address>
        <city>Hemer</city>
        <zip>58675</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Furche</name>
      <address>
        <city>Herne</city>
        <zip>44623</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Dr. Bruch</name>
      <address>
        <city>Herne</city>
        <zip>44629</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Schlichting</name>
      <address>
        <city>Herne</city>
        <zip>44649</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Augusta-Kranken-Anstalt gGmbH Thoraxzentrum Ruhrgebiet</name>
      <address>
        <city>Herne</city>
        <zip>44651</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Elisabeth-Hospital Herten gGmbH</name>
      <address>
        <city>Herten</city>
        <zip>45699</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lungenfachklinik Immenhausen</name>
      <address>
        <city>Immenhausen</city>
        <zip>34376</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Dres. Dobler/Turin</name>
      <address>
        <city>Karlstadt</city>
        <zip>97753</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ambulantes Herzzentrum Kassel</name>
      <address>
        <city>Kassel</city>
        <zip>34121</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Siegfried Frickel</name>
      <address>
        <city>Kempen</city>
        <zip>47906</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Krater</name>
      <address>
        <city>Krefeld</city>
        <zip>47799</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helios Klinikum Krefeld</name>
      <address>
        <city>Krefeld</city>
        <zip>47805</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St.-Vinzenz Hospital</name>
      <address>
        <city>KÃ¶ln</city>
        <zip>50733</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Fritsch</name>
      <address>
        <city>KÃ¶ln</city>
        <zip>50737</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Malteser Krankenhaus St.Hildegardis</name>
      <address>
        <city>KÃ¶ln</city>
        <zip>50931</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prof. Franzen Institut</name>
      <address>
        <city>KÃ¶ln</city>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Anselm BÃ¤umer</name>
      <address>
        <city>KÃ¶ln</city>
        <zip>51065</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Dres. Gysan/Heinzler/May</name>
      <address>
        <city>KÃ¶ln</city>
        <zip>51105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Dahme-Spreewald GmbH</name>
      <address>
        <city>KÃ¶nigs Wusterhausen</city>
        <zip>15711</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinikum Leipzig-Herzzentrum</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helios Krankenhaus Leisnig</name>
      <address>
        <city>Leisnig</city>
        <zip>04703</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Dr. Hilgedieck/Sava</name>
      <address>
        <city>Lengerich</city>
        <zip>49525</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Faber</name>
      <address>
        <city>Lindlar</city>
        <zip>51784</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ã„rztezentrum Holthausen-Biene</name>
      <address>
        <city>Lingen</city>
        <zip>49808</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinikum Schleswig-Holstein Campus LÃ¼beck-Kardiologie</name>
      <address>
        <city>LÃ¼beck</city>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinikum Schleswig-Holstein Campus LÃ¼beck-Schlaflabor</name>
      <address>
        <city>LÃ¼beck</city>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der Johannes Gutenberg-UniversitÃ¤t Mainz</name>
      <address>
        <city>Mainz</city>
        <zip>55101</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiopraxis Ingelheim</name>
      <address>
        <city>Mainz</city>
        <zip>55116</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinikum Mannheim-Schlafmedizin</name>
      <address>
        <city>Mannheim</city>
        <zip>68135</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Dres. Heifer/Loster/Schernus</name>
      <address>
        <city>Mannheim</city>
        <zip>68161</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis fÃ¼r Herz &amp; GefÃ¤ÃŸe</name>
      <address>
        <city>Mannheim</city>
        <zip>68161</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinik Mannheim-Kardiologie</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Dres. Brandt / Jakobs</name>
      <address>
        <city>Mannheim</city>
        <zip>68305</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinikum GieÃŸen / Marburg, Standort Marburg-Schlafmedizin</name>
      <address>
        <city>Marburg</city>
        <zip>35033</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinikum GieÃŸen/Marburg Standort Marburg-Kardiologie</name>
      <address>
        <city>Marburg</city>
        <zip>35043</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Schnabel</name>
      <address>
        <city>Meissen</city>
        <zip>01662</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Dr. Jocham</name>
      <address>
        <city>Memmingen</city>
        <zip>87700</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis FÃ¼r Kardiologie Dr. med. Menz</name>
      <address>
        <city>Menden</city>
        <zip>58706</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Bethanien</name>
      <address>
        <city>Moers</city>
        <zip>47441</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. SchÃ¶n</name>
      <address>
        <city>MÃ¼hldorf</city>
        <zip>84453</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus MÃ¼lheim</name>
      <address>
        <city>MÃ¼lheim an der Ruhr</city>
        <zip>45468</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologie am Rotkreuzplatz</name>
      <address>
        <city>MÃ¼nchen</city>
        <zip>80634</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LungenÃ¤rzte am Rotkreuzplatz</name>
      <address>
        <city>MÃ¼nchen</city>
        <zip>80634</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Dres. Wauer / Windstetter</name>
      <address>
        <city>MÃ¼nchen</city>
        <zip>80799</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Herholz</name>
      <address>
        <city>MÃ¼nchen</city>
        <zip>80809</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik Augustinum MÃ¼nchen</name>
      <address>
        <city>MÃ¼nchen</city>
        <zip>81375</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dres. BÃ¶hme/Linke</name>
      <address>
        <city>MÃ¼nchen</city>
        <zip>81667</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Muradi</name>
      <address>
        <city>MÃ¼nster</city>
        <zip>29633</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinikum MÃ¼nster</name>
      <address>
        <city>MÃ¼nster</city>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis fÃ¼r Kardiologie Dr. med. Hewing</name>
      <address>
        <city>MÃ¼nster</city>
        <zip>48151</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lukaskrankenhaus GmbH</name>
      <address>
        <city>Neuss</city>
        <zip>41464</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Nienburg</name>
      <address>
        <city>Nienburg</city>
        <zip>31582</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum NÃ¼rnberg Nord</name>
      <address>
        <city>NÃ¼rnberg</city>
        <zip>90419</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum NÃ¼rnberg SÃ¼d</name>
      <address>
        <city>NÃ¼rnberg</city>
        <zip>90471</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Gumbrecht</name>
      <address>
        <city>Ochtrup</city>
        <zip>48607</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. WiethÃ¶lter</name>
      <address>
        <city>Radebeul</city>
        <zip>01445</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis fÃ¼r Kardiologie Ratingen</name>
      <address>
        <city>Ratingen</city>
        <zip>40878</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. FrÃ¶hlich</name>
      <address>
        <city>Ratingen</city>
        <zip>40885</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DRK Krankenhaus MÃ¶lln-Ratzeburg</name>
      <address>
        <city>Ratzeburg</city>
        <zip>23909</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ambulantes CardiovaskulÃ¤res Centrum</name>
      <address>
        <city>Ravensburg</city>
        <zip>88212</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Dr. Weber/Dr. Feja</name>
      <address>
        <city>Recklinghausen</city>
        <zip>45657</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Knappschafts-Krankenhaus Recklinghausen</name>
      <address>
        <city>Recklinghausen</city>
        <zip>45657</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinikum Regensburg</name>
      <address>
        <city>Regensburg</city>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Reinbek St. Adolf-Stift</name>
      <address>
        <city>Reinbek</city>
        <zip>21465</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Hein</name>
      <address>
        <city>Reinbek</city>
        <zip>21465</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Nebel</name>
      <address>
        <city>Rheine</city>
        <zip>48429</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Kestermann</name>
      <address>
        <city>Rheine</city>
        <zip>48431</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Heinze</name>
      <address>
        <city>Schwerte</city>
        <zip>58239</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Ebeling</name>
      <address>
        <city>SchÃ¶nefeld</city>
        <zip>12529</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxisgemeinschaft Cardio-Soest</name>
      <address>
        <city>Soest</city>
        <zip>59494</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Facharztzentrum Sonneberg</name>
      <address>
        <city>Sonneberg</city>
        <zip>96515</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kreiskrankenhaus Stollberg GmbH</name>
      <address>
        <city>Stollberg</city>
        <zip>09366</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Uelzen GmbH</name>
      <address>
        <city>Uelzen</city>
        <zip>29525</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herzklinik Ulm Dr. Haerer und Partner</name>
      <address>
        <city>Ulm</city>
        <zip>89077</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zentrum fÃ¼r Innere Medizin Uni Ulm</name>
      <address>
        <city>Ulm</city>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Katharinen Hospital Unna</name>
      <address>
        <city>Unna</city>
        <zip>59423</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Burkhard-Meier</name>
      <address>
        <city>Viersen</city>
        <zip>41747</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Gerritsen</name>
      <address>
        <city>Waldkraiburg</city>
        <zip>84478</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fachkliniken Wangen</name>
      <address>
        <city>Wangen</city>
        <zip>88239</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stiftungsklinik WeiÃŸenhorn</name>
      <address>
        <city>WeiÃŸenhorn</city>
        <zip>89264</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Vrettos</name>
      <address>
        <city>Witten</city>
        <zip>58452</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dr. Rudolf/ Dr. Bernhardt</name>
      <address>
        <city>Worms</city>
        <zip>67547</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MissionsÃ¤rztliche Klinik WÃ¼rzburg</name>
      <address>
        <city>WÃ¼rzburg</city>
        <zip>97074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinikum WÃ¼rzburg</name>
      <address>
        <city>WÃ¼rzburg</city>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Evangel. Khs ZweibrÃ¼cken</name>
      <address>
        <city>ZweibrÃ¼cken</city>
        <zip>66482</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9700</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UllevÃ¥l University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0407</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital, Rikshospitalet</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stavanger AS</name>
      <address>
        <city>Stavanger</city>
        <zip>4011</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital / Ã–stra</name>
      <address>
        <city>GÃ¶teborg</city>
        <zip>41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital / Ã–stra</name>
      <address>
        <city>GÃ¶teborg</city>
        <zip>U/6 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SpecialistlÃ¤karmottagning Residenset AB</name>
      <address>
        <city>JÃ¶nkÃ¶ping</city>
        <zip>55316</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Skaraborgs Hospital</name>
      <address>
        <city>LidkÃ¶ping</city>
        <zip>53185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LinkÃ¶ping University Hospital</name>
      <address>
        <city>LinkÃ¶ping</city>
        <zip>58185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiocentro Ticino</name>
      <address>
        <city>Lugano</city>
        <zip>6900</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Regionale di Lugano</name>
      <address>
        <city>Lugano</city>
        <zip>6903</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Castle Hill Hospital</name>
      <address>
        <city>Cottingham</city>
        <state>East Yorkshire</state>
        <zip>HU165JQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chesterfield Royal Hospital</name>
      <address>
        <city>Chesterfield</city>
        <zip>Calow S44 5DX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brompton Hospital</name>
      <address>
        <city>London</city>
        <zip>SW36NP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Freeman Hospital</name>
      <address>
        <city>Newcastle</city>
        <zip>NE7 7DN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Musgrove Park Hospital</name>
      <address>
        <city>Taunton</city>
        <zip>TA1 5DA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Wolverhampton Hospitals NHS Trust</name>
      <address>
        <city>Wolverhampton</city>
        <zip>WV10 0QP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Czechia</country>
    <country>Denmark</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <results_reference>
    <citation>Cowie MR, Wegscheider K, Teschler H. Adaptive Servo-Ventilation for Central Sleep Apnea in Heart Failure. N Engl J Med. 2016 Feb 18;374(7):690-1. doi: 10.1056/NEJMc1515007.</citation>
    <PMID>26886528</PMID>
  </results_reference>
  <results_reference>
    <citation>Eulenburg C, Wegscheider K, Woehrle H, Angermann C, d'Ortho MP, Erdmann E, Levy P, Simonds AK, Somers VK, Zannad F, Teschler H, Cowie MR. Mechanisms underlying increased mortality risk in patients with heart failure and reduced ejection fraction randomly assigned to adaptive servoventilation in the SERVE-HF study: results of a secondary multistate modelling analysis. Lancet Respir Med. 2016 Nov;4(11):873-881. doi: 10.1016/S2213-2600(16)30244-2. Epub 2016 Aug 31.</citation>
    <PMID>27592224</PMID>
  </results_reference>
  <results_reference>
    <citation>Woehrle H, Cowie MR, Eulenburg C, Suling A, Angermann C, d'Ortho MP, Erdmann E, Levy P, Simonds AK, Somers VK, Zannad F, Teschler H, Wegscheider K. Adaptive servo ventilation for central sleep apnoea in heart failure: SERVE-HF on-treatment analysis. Eur Respir J. 2017 Aug 31;50(2). pii: 1601692. doi: 10.1183/13993003.01692-2016. Print 2017 Aug.</citation>
    <PMID>28860264</PMID>
  </results_reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>February 14, 2008</study_first_submitted>
  <study_first_submitted_qc>August 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2008</study_first_posted>
  <results_first_submitted>April 28, 2017</results_first_submitted>
  <results_first_submitted_qc>April 29, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">May 12, 2020</results_first_posted>
  <last_update_submitted>April 29, 2020</last_update_submitted>
  <last_update_submitted_qc>April 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>heart failure (HF)</keyword>
  <keyword>sleep disordered breathing (SDB)</keyword>
  <keyword>sleep apnea</keyword>
  <keyword>left ventricular systolic dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Sleep Apnea, Central</mesh_term>
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Treatment Group</title>
          <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
        </group>
        <group group_id="P2">
          <title>Control Group</title>
          <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="666"/>
                <participants group_id="P2" count="659"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="583"/>
                <participants group_id="P2" count="578"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="83"/>
                <participants group_id="P2" count="81"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Treatment Group</title>
          <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
        </group>
        <group group_id="B2">
          <title>Control Group</title>
          <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="666"/>
            <count group_id="B2" value="659"/>
            <count group_id="B3" value="1325"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.6" spread="9.5"/>
                    <measurement group_id="B2" value="69.3" spread="10.4"/>
                    <measurement group_id="B3" value="69.5" spread="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="67"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="127"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="599"/>
                    <measurement group_id="B2" value="599"/>
                    <measurement group_id="B3" value="1198"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Czechia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Netherlands</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sweden</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Norway</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Finland</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Denmark</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United Kingdom</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Australia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>France</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="119"/>
                    <measurement group_id="B2" value="123"/>
                    <measurement group_id="B3" value="242"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Switzerland</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Germany</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="467"/>
                    <measurement group_id="B2" value="459"/>
                    <measurement group_id="B3" value="926"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>NYHA class</title>
          <description>New York Heart Association (NYHA). Class I: No Limitation of physical activity. [...] Class II: Slight Limitation of physical activity. Comfortable at rest, but less than ordinary physical activity results in undue breathlessness, fatigue, or palpitations. Class III: Marked Limitation of physical activity. Comfortable at rest, but less than ordinary physical activity results in [...].Class IV: Unable to carry on any physical activity without discomfort. Symptoms at rest can be present. If any physical act is undertaken, discomfort is increased. Ref.: ESC Guidelines 2016 (c) ESC 2016</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>NYHA II</title>
                  <measurement_list>
                    <measurement group_id="B1" value="195"/>
                    <measurement group_id="B2" value="194"/>
                    <measurement group_id="B3" value="389"/>
                  </measurement_list>
                </category>
                <category>
                  <title>NYHA III</title>
                  <measurement_list>
                    <measurement group_id="B1" value="456"/>
                    <measurement group_id="B2" value="454"/>
                    <measurement group_id="B3" value="910"/>
                  </measurement_list>
                </category>
                <category>
                  <title>NYHA IV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>not assessed</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetes</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="254"/>
                    <measurement group_id="B2" value="252"/>
                    <measurement group_id="B3" value="506"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cause of Heart Failure</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>ischemic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="390"/>
                    <measurement group_id="B2" value="366"/>
                    <measurement group_id="B3" value="756"/>
                  </measurement_list>
                </category>
                <category>
                  <title>nonischemic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="263"/>
                    <measurement group_id="B2" value="276"/>
                    <measurement group_id="B3" value="539"/>
                  </measurement_list>
                </category>
                <category>
                  <title>not assessed</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Electrocardiographic Finding</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>sinus rhythm</title>
                  <measurement_list>
                    <measurement group_id="B1" value="372"/>
                    <measurement group_id="B2" value="395"/>
                    <measurement group_id="B3" value="767"/>
                  </measurement_list>
                </category>
                <category>
                  <title>atrial fibrillation</title>
                  <measurement_list>
                    <measurement group_id="B1" value="178"/>
                    <measurement group_id="B2" value="147"/>
                    <measurement group_id="B3" value="325"/>
                  </measurement_list>
                </category>
                <category>
                  <title>other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="100"/>
                    <measurement group_id="B2" value="104"/>
                    <measurement group_id="B3" value="204"/>
                  </measurement_list>
                </category>
                <category>
                  <title>not assessed</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Implanted device</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>no device</title>
                  <measurement_list>
                    <measurement group_id="B1" value="304"/>
                    <measurement group_id="B2" value="295"/>
                    <measurement group_id="B3" value="599"/>
                  </measurement_list>
                </category>
                <category>
                  <title>non-CRT(cardiacresynchronisation therapy)pacemaker</title>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="61"/>
                  </measurement_list>
                </category>
                <category>
                  <title>ICD (implantable cardioverter defibrillator)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="163"/>
                    <measurement group_id="B2" value="161"/>
                    <measurement group_id="B3" value="324"/>
                  </measurement_list>
                </category>
                <category>
                  <title>CRT-P</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
                <category>
                  <title>CRT-D</title>
                  <measurement_list>
                    <measurement group_id="B1" value="153"/>
                    <measurement group_id="B2" value="153"/>
                    <measurement group_id="B3" value="306"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Concomitant cardiac medication</title>
          <population>The values count the number of patients who have taken the respective medication.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>ACE inhibitor or ARB(AT1 recept blocker)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="613"/>
                    <measurement group_id="B2" value="603"/>
                    <measurement group_id="B3" value="1216"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>beta-blocker</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="612"/>
                    <measurement group_id="B2" value="611"/>
                    <measurement group_id="B3" value="1223"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>aldosterone antagonist</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="316"/>
                    <measurement group_id="B2" value="325"/>
                    <measurement group_id="B3" value="641"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>diuretic</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="561"/>
                    <measurement group_id="B2" value="561"/>
                    <measurement group_id="B3" value="1122"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>cardiac glycoside</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="657"/>
                    <count group_id="B3" value="1323"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="149"/>
                    <measurement group_id="B2" value="124"/>
                    <measurement group_id="B3" value="273"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>antiarrhythmic drug</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="666"/>
                    <count group_id="B2" value="659"/>
                    <count group_id="B3" value="1325"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="128"/>
                    <measurement group_id="B2" value="89"/>
                    <measurement group_id="B3" value="217"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>All Cause Mortality or Unplanned Hospitalisation/Prolongation of Hospitalisation for Worsening Heart Failure</title>
        <time_frame>time to first event, assessed for up to 70 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>All Cause Mortality or Unplanned Hospitalisation/Prolongation of Hospitalisation for Worsening Heart Failure</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="360"/>
                    <measurement group_id="O2" value="335"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cardiovascular Mortality or Unplanned Hospitalisation/Prolongation of Hospitalisation for Worsening Heart Failure</title>
        <time_frame>time to first event, assessed for up to 70 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiovascular Mortality or Unplanned Hospitalisation/Prolongation of Hospitalisation for Worsening Heart Failure</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="345"/>
                    <measurement group_id="O2" value="317"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>All Cause Mortality or All Cause Unplanned Hospitalisation/Prolongation of Hospitalisation</title>
        <time_frame>time to first event, assessed for up to 70 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>All Cause Mortality or All Cause Unplanned Hospitalisation/Prolongation of Hospitalisation</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="482"/>
                    <measurement group_id="O2" value="465"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Death From Any Cause</title>
        <time_frame>the last follow up or at the last available observation within Follow Up (FU), assessed for up to 70 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Death From Any Cause</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="232"/>
                    <measurement group_id="O2" value="193"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Non-cardiovascular Death</title>
        <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Non-cardiovascular Death</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cardiovascular Death</title>
        <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiovascular Death</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="199"/>
                    <measurement group_id="O2" value="158"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Unplanned Hospitalisation/Prolongation of Hospitalisation Due to Worsening of Heart Failure</title>
        <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Unplanned Hospitalisation/Prolongation of Hospitalisation Due to Worsening of Heart Failure</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="287"/>
                    <measurement group_id="O2" value="272"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Unplanned Hospitalisation/Prolongation of Hospitalisation for Other Reasons or Death</title>
        <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Unplanned Hospitalisation/Prolongation of Hospitalisation for Other Reasons or Death</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="452"/>
                    <measurement group_id="O2" value="448"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adequate Shock in Patients With ICD (Evaluation of Appropriateness Will Also be Made by the Endpoint Review Committee, ERC), Long-Term Atrial Defibrillator Insertion or Cardiovascular Death</title>
        <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Adequate Shock in Patients With ICD (Evaluation of Appropriateness Will Also be Made by the Endpoint Review Committee, ERC), Long-Term Atrial Defibrillator Insertion or Cardiovascular Death</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                    <measurement group_id="O2" value="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>First Survived Resuscitation for Any Reason (Evaluation Will Also be Made by the ERC)</title>
        <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>First Survived Resuscitation for Any Reason (Evaluation Will Also be Made by the ERC)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>First Survived Resuscitation of Sudden Cardiac Arrest (Evaluation Will Also be Made by the ERC)</title>
        <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>First Survived Resuscitation of Sudden Cardiac Arrest (Evaluation Will Also be Made by the ERC)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Age Baseline</title>
        <time_frame>1 x at Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Age Baseline</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.6" spread="9.5"/>
                    <measurement group_id="O2" value="69.3" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Body Weight Baseline</title>
        <time_frame>1 x at baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Body Weight Baseline</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.6" spread="15.8"/>
                    <measurement group_id="O2" value="86.1" spread="17.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Body Mass Index (BMI) Baseline</title>
        <time_frame>1 x baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Body Mass Index (BMI) Baseline</title>
          <units>kg/cm2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.4" spread="4.7"/>
                    <measurement group_id="O2" value="28.6" spread="5.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Left Ventricular Ejection Fraction at Baseline</title>
        <time_frame>1x at baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Left Ventricular Ejection Fraction at Baseline</title>
          <units>%total vol ventricle</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.2" spread="7.9"/>
                    <measurement group_id="O2" value="32.5" spread="8.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Blood Pressure Systolic Baseline</title>
        <time_frame>1 x at baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Blood Pressure Systolic Baseline</title>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="122.3" spread="19.0"/>
                    <measurement group_id="O2" value="122.1" spread="19.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Blood Pressure Diastolic Baseline</title>
        <time_frame>1 x at baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Blood Pressure Diastolic Baseline</title>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.7" spread="11.3"/>
                    <measurement group_id="O2" value="73.3" spread="11.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hemoglobine Baseline</title>
        <time_frame>1 x at baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Hemoglobine Baseline</title>
          <units>g/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.8" spread="1.6"/>
                    <measurement group_id="O2" value="13.9" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Creatinine Baseline</title>
        <time_frame>1 x at baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Creatinine Baseline</title>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="0.6"/>
                    <measurement group_id="O2" value="1.4" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Glomerular Filtration Rate Baseline</title>
        <time_frame>1 x at baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Glomerular Filtration Rate Baseline</title>
          <units>ml/min/1.73m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.8" spread="21.1"/>
                    <measurement group_id="O2" value="59.3" spread="20.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>6-Min Walk Distance</title>
        <time_frame>1 x at baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>6-Min Walk Distance</title>
          <units>m</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="334.0" spread="126.4"/>
                    <measurement group_id="O2" value="337.9" spread="127.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Epworth Sleepiness Scale (ESS)</title>
        <description>Measure Description: ESS is a self-administered questionnaire. It contains 8 questions. Questions are rated on a 4-point Likert scale (0-3); 0= would never doze, 3=high Chance of dozing. Range of scores 0-24. Global score= sum of all item scores. Copyright (c)MW Johns</description>
        <time_frame>1 x at baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Epworth Sleepiness Scale (ESS)</title>
          <description>Measure Description: ESS is a self-administered questionnaire. It contains 8 questions. Questions are rated on a 4-point Likert scale (0-3); 0= would never doze, 3=high Chance of dozing. Range of scores 0-24. Global score= sum of all item scores. Copyright (c)MW Johns</description>
          <units>total score ESS</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.0" spread="4.3"/>
                    <measurement group_id="O2" value="7.1" spread="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Apnoea-Hypopnea-Index (AHI) at Baseline</title>
        <description>Measure Description: The AHI is an index to describe the severity of Sleep Apnea. Apnea is cessation of breathing during sleep. Hypopnea is diminished breathing during sleep. The number of Apneas and Hypopneas are added up and divided by hours of sleep (Apneas + Hypopneas per hour). An AHI ranging from 5-15 describes mild Sleep Apnea. AHI 15-30 describes moderate Sleep Apnea. AHI &gt;30 describes severe Sleep Apnea.</description>
        <time_frame>1 x at baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Apnoea-Hypopnea-Index (AHI) at Baseline</title>
          <description>Measure Description: The AHI is an index to describe the severity of Sleep Apnea. Apnea is cessation of breathing during sleep. Hypopnea is diminished breathing during sleep. The number of Apneas and Hypopneas are added up and divided by hours of sleep (Apneas + Hypopneas per hour). An AHI ranging from 5-15 describes mild Sleep Apnea. AHI 15-30 describes moderate Sleep Apnea. AHI &gt;30 describes severe Sleep Apnea.</description>
          <units>events/hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.2" spread="12.7"/>
                    <measurement group_id="O2" value="31.7" spread="13.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Central Apnoea Index/Total AHI</title>
        <description>Measure Description: Central apneas are partial or complete cessations of airflow caused by reduced or stopped neural Stimulation of the breathing muscles. For comparison: In obstructive apneas are caused by blocked airways that shut off the air although the breathing Stimulus is working.</description>
        <time_frame>1 x at baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Central Apnoea Index/Total AHI</title>
          <description>Measure Description: Central apneas are partial or complete cessations of airflow caused by reduced or stopped neural Stimulation of the breathing muscles. For comparison: In obstructive apneas are caused by blocked airways that shut off the air although the breathing Stimulus is working.</description>
          <units>%central/totalapnea</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.6" spread="28.9"/>
                    <measurement group_id="O2" value="46.5" spread="30.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Central AHI/Total AHI at Baseline</title>
        <time_frame>1 x at baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Central AHI/Total AHI at Baseline</title>
          <units>Central/totalAHI%</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.8" spread="15.5"/>
                    <measurement group_id="O2" value="81.8" spread="15.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oxygen Desaturation Index (ODI) at Baseline</title>
        <description>Number of oxygen desaturations per hour at baseline</description>
        <time_frame>1 x at baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Oxygen Desaturation Index (ODI) at Baseline</title>
          <description>Number of oxygen desaturations per hour at baseline</description>
          <units>events/hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.1" spread="17.7"/>
                    <measurement group_id="O2" value="32.8" spread="19.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oxygen Saturation Baseline</title>
        <time_frame>1 x at baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Oxygen Saturation Baseline</title>
          <units>%total hemoglobine</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.8" spread="2.3"/>
                    <measurement group_id="O2" value="92.8" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time With Oxygen Saturation Below 90%</title>
        <time_frame>1 x at baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Time With Oxygen Saturation Below 90%</title>
          <units>min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="659"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.5" spread="68.2"/>
                    <measurement group_id="O2" value="55.7" spread="73.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time Until Unplanned Hospitalisation/Prolongation of Hospitalisation for Cardiovascular Cause or Cardiovascular Death/ Time Frame</title>
        <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
        <population>Data have not been collected.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Time Until Unplanned Hospitalisation/Prolongation of Hospitalisation for Cardiovascular Cause or Cardiovascular Death/ Time Frame</title>
          <population>Data have not been collected.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent of Follow up Days Which Patient Survives and is Not Hospitalized/Hospital Stay is Not Prolonged for Cardiovascular Cause</title>
        <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
        <population>Data have not been collected</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Percent of Follow up Days Which Patient Survives and is Not Hospitalized/Hospital Stay is Not Prolonged for Cardiovascular Cause</title>
          <population>Data have not been collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in NYHA Classification as Compared to Baseline</title>
        <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
        <population>Data have not been collected</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in NYHA Classification as Compared to Baseline</title>
          <population>Data have not been collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in QoL (Minnesota) as Compared to Baseline</title>
        <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
        <population>Data have not been collected</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in QoL (Minnesota) as Compared to Baseline</title>
          <population>Data have not been collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Renal Function (Based on Serum Creatinine) as Compared to Baseline</title>
        <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
        <population>Data have not been collected</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in Renal Function (Based on Serum Creatinine) as Compared to Baseline</title>
          <population>Data have not been collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Six Minute Walking Distance (6MWD) as Compared to Baseline</title>
        <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
        <population>Data have not been collected</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in Six Minute Walking Distance (6MWD) as Compared to Baseline</title>
          <population>Data have not been collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes of AHI and Oxygen Desaturation Index Compared to Baseline</title>
        <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
        <population>Data have not been collected</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Changes of AHI and Oxygen Desaturation Index Compared to Baseline</title>
          <population>Data have not been collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>AHI Below 10 Per Hour at Twelve Months and ODI Below 5 Per Hour at Twelve Months</title>
        <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
        <population>Data have not been collected</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>AHI Below 10 Per Hour at Twelve Months and ODI Below 5 Per Hour at Twelve Months</title>
          <population>Data have not been collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Atrial Fibrillation at Follow-up Visits</title>
        <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
        <population>Data have not been collected</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Atrial Fibrillation at Follow-up Visits</title>
          <population>Data have not been collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number and Cost of Hospitalisations (With Tariff/DRG, Diagnoses and Procedures for Calculating DRG or Length of Stay and Level of Care Provided)</title>
        <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
        <population>Data have not been collected</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Number and Cost of Hospitalisations (With Tariff/DRG, Diagnoses and Procedures for Calculating DRG or Length of Stay and Level of Care Provided)</title>
          <population>Data have not been collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Difference in Utilities / QoL (Minnesota and EQ5D) Compared to Control Arm</title>
        <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
        <population>Data have not been collected</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Difference in Utilities / QoL (Minnesota and EQ5D) Compared to Control Arm</title>
          <population>Data have not been collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Difference in Cost of Resources Consumed</title>
        <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
        <population>Data have not been collected</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Difference in Cost of Resources Consumed</title>
          <population>Data have not been collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incremental Cost-efficacy Ratio</title>
        <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
        <population>Data have not been collected</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Incremental Cost-efficacy Ratio</title>
          <population>Data have not been collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incremental Cost-utility Ratio</title>
        <time_frame>the last follow up or at the last available observation within FU, assessed for up to 70 weeks</time_frame>
        <population>Data have not been collected</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group</title>
            <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC-american college of cardiology/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
          </group>
        </group_list>
        <measure>
          <title>Incremental Cost-utility Ratio</title>
          <population>Data have not been collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Treatment Group</title>
          <description>treatment with Adaptive Servoventilation (Europe: AutoSet CS (USA: VPAP Adapt SV)) + standard medical therapy according to applicable guidelines (ESC, ACC/AHA)
Europe: AutoSet CS (USA: VPAP Adapt SV): At least 3 hours average daily usage time</description>
        </group>
        <group group_id="E2">
          <title>Control Group</title>
          <description>standard medical therapy according to applicable guidelines (ESC, ACC/AHA)</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="232" subjects_at_risk="666"/>
                <counts group_id="E2" subjects_affected="193" subjects_at_risk="659"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="482" subjects_at_risk="666"/>
                <counts group_id="E2" subjects_affected="465" subjects_at_risk="659"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiovascular death</sub_title>
                <counts group_id="E1" events="199" subjects_affected="199" subjects_at_risk="666"/>
                <counts group_id="E2" events="158" subjects_affected="158" subjects_at_risk="659"/>
              </event>
              <event>
                <sub_title>Firt secondary endpoint</sub_title>
                <description>First Event of cardiovascular death, lifesaving cardiovascular Intervention, unplanned hospitalization for worsening chronic heart failure</description>
                <counts group_id="E1" events="345" subjects_affected="345" subjects_at_risk="666"/>
                <counts group_id="E2" events="317" subjects_affected="317" subjects_at_risk="659"/>
              </event>
              <event>
                <sub_title>Unplanned hospitalization for worsening heart failure</sub_title>
                <counts group_id="E1" events="287" subjects_affected="287" subjects_at_risk="666"/>
                <counts group_id="E2" events="272" subjects_affected="272" subjects_at_risk="659"/>
              </event>
              <event>
                <sub_title>Heart transplantation</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="666"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="659"/>
              </event>
              <event>
                <sub_title>Implantation of long-term VentricularAssistDev</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="666"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="659"/>
              </event>
              <event>
                <sub_title>Resuscitation for cardiac arrest</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="666"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="659"/>
              </event>
              <event>
                <sub_title>Appropriate Shock for ventricular arrhythmia</sub_title>
                <counts group_id="E1" events="45" subjects_affected="45" subjects_at_risk="666"/>
                <counts group_id="E2" events="65" subjects_affected="65" subjects_at_risk="659"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Primary end point</sub_title>
                <description>First event of death from any cause, lifesaving cardiovascular intervention, unplanned hospitalization for worsening chronic heart failure</description>
                <counts group_id="E1" events="360" subjects_affected="360" subjects_at_risk="666"/>
                <counts group_id="E2" events="335" subjects_affected="335" subjects_at_risk="659"/>
              </event>
              <event>
                <sub_title>Second secondary endpoint</sub_title>
                <description>First event of death from any cause, lifesaving cardiovascular intervention, unplanned hospitalization for any cause</description>
                <counts group_id="E1" events="482" subjects_affected="482" subjects_at_risk="666"/>
                <counts group_id="E2" events="465" subjects_affected="465" subjects_at_risk="659"/>
              </event>
              <event>
                <sub_title>Hospitalization for any cause</sub_title>
                <counts group_id="E1" events="452" subjects_affected="452" subjects_at_risk="666"/>
                <counts group_id="E2" events="448" subjects_affected="448" subjects_at_risk="659"/>
              </event>
              <event>
                <sub_title>Resuscitation</sub_title>
                <counts group_id="E1" events="25" subjects_affected="25" subjects_at_risk="666"/>
                <counts group_id="E2" events="19" subjects_affected="19" subjects_at_risk="659"/>
              </event>
              <event>
                <sub_title>Noncardiovascular death</sub_title>
                <counts group_id="E1" events="33" subjects_affected="33" subjects_at_risk="666"/>
                <counts group_id="E2" events="35" subjects_affected="35" subjects_at_risk="659"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="666"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="659"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Martin R. Cowie, MD</name_or_title>
      <organization>Department of Cardiology, Imperial College London, Dovehouse St., London SW3 6LY, United Kingdom</organization>
      <phone>+44 (0)20 7589 0 ext 5111</phone>
      <email>m.cowie@imperial.ac.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

